Tiantan Biological / China Biologic (泰邦生物集团)

Beijing, China · Founded 2002 · $5.1B raised

Headquarters
Beijing
Employees
1001–5000
Founded
2002
Business Model
B2B
Total Funding
$5.1B
Last Round
$300.0M Growth EquityAug 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Taibang Biologic Group (formerly listed as China Biologic Products Holdings, Inc.) is a leading Chinese biopharmaceutical company specializing in the collection, manufacturing, and commercialization of human plasma-based biological products. Originally established as Taibang Biologic Group in Beijing in 2002, the company provides a comprehensive range of plasma-derived therapies serving hospitals and healthcare institutions across China. The company was taken private in a transaction led by Centurium Capital and has 1,000–5,000 employees.

Summary

Tiantan Biological / China Biologic (泰邦生物集团) is a Biotech company based in Beijing, China, founded in 2002. It has raised $5.1B in total across 2 rounds, most recently a $300.0M Growth Equity round in Aug 2022. Investors include Abu Dhabi Investment Authority, Centurium Capital and GIC.

Funding History

Growth EquityGrowth EquityAug 2022
$300.0M

Sign up to see all 2 events

Funding: Private Equity through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tiantan Biological / China Biologic (泰邦生物集团) on Indexed.vc
<a href="https://indexed.vc/companies/tiantan-biological-china-biologic"><img src="https://indexed.vc/api/badge/company/tiantan-biological-china-biologic" alt="Tiantan Biological / China Biologic (泰邦生物集团) on Indexed.vc" width="260" height="76" /></a>